Cargando…

Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases

INTRODUCTION: To assess the safety profile of the intravitreal ranibizumab biosimilar molecule, Razumab(®) (Intas Pharmaceuticals, Ahmedabad, India) in chorioretinal disorders under real-world conditions. METHODS: This was a multicenter, retrospective chart review which included patients from 15 cen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Debdulal, Stewart, Michael W., Sheth, Jay U., Sinha, Tushar K., Boral, Subhendu, Das, Arnab, Mondal, Soumen, Mukherjee, Angshuman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079600/ https://www.ncbi.nlm.nih.gov/pubmed/33864599 http://dx.doi.org/10.1007/s40123-021-00345-2

Ejemplares similares

Comparison of Innovator vs. Biosimilar Ranibizumab in Treating Diabetic Macular Edema: A Multicenter Retrospective Study
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence
por: Chakraborty, Debdulal, et al.
Publicado: (2023)

Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case series
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Intravitreal Injection of Brolucizumab for Recalcitrant Macular Edema due to Central Retinal Vein Occlusion: A Small Case Series
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series
por: Chakraborty, Debdulal, et al.
Publicado: (2021)

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
por: Chakraborty, Debdulal, et al.
Publicado: (2021)

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Clinical efficacy and safety of Razumab® (CESAR) study: Our experience with the world's first biosimilar Ranibizumab
por: Verma, Lalit, et al.
Publicado: (2021)

Ultra-widefield image of a toxocara granuloma with an adjacent retinal break and retinal detachment
por: Chakraborty, Debdulal, et al.
Publicado: (2019)

Incidence, clinical features, risk factors, and outcomes of Intraocular inflammation following Brolucizumab in Indian eyes – A multicentric study
por: Chakraborty, Debdulal, et al.
Publicado: (2023)

A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
por: Sharma, Shashikant, et al.
Publicado: (2020)

Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World’s First Biosimilar Ranibizumab): A Comprehensive Review
por: Sharma, Shashikant, et al.
Publicado: (2021)

A Multicenter, Retrospective Study (RE-ENACT 2) on the Use of Razumab™ (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration
por: Sharma, Shashikant, et al.
Publicado: (2019)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
por: Sharma, Shashikant, et al.
Publicado: (2021)

Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages
por: Boral, Subhendu Kumar, et al.
Publicado: (2023)

A novel standardized reproducible method to calculate the area of internal limiting membrane peeled intra-operatively in macular hole surgery by using a video overlay—A long-term study in cases of idiopathic macular holes
por: Boral, Subhendu K, et al.
Publicado: (2020)

Long-term clinical outcomes of submacular blood removal with isolated autologous retinal pigment epithelium-choroid patch graft transplantation in long-standing large-sized submacular hematomas: An Indian experience
por: Boral, Subhendu Kumar, et al.
Publicado: (2020)

Variable clinical profile of foveal hypoplasia in albinism
por: Kumar, Kshitiz, et al.
Publicado: (2020)

Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
por: Soman, Manoj, et al.
Publicado: (2022)

Commentary: Indistinct retinal outer layers in the walls of idiopathic full thickness macular hole - A potential predictive biomarker for surgical outcomes
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Commentary: To evaluate the functional and anatomical outcomes for autologous retinal autograft with Finesse™ Flex Loop for failed macular holes
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Commentary: Clinical profile, demographic distribution, and outcomes of ocular siderosis: Electronic medical record-driven big data analytics from an eye care network in India
por: Chakraborty, Debdulal, et al.
Publicado: (2023)

Intravitreal Voriconazole for Treatment of Bilateral Endogenous Candida Chorioretinitis
por: Sim, Ha Eun, et al.
Publicado: (2020)

Chorioretinal paracoccidioidomycosis treated with intravitreal voriconazole and therapeutic vitrectomy
por: Oke, Isdin, et al.
Publicado: (2021)

Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration
por: Kaiser, Peter K., et al.
Publicado: (2023)

Anatomical and functional outcomes one year after vitrectomy and retinal massage for large macular holes
por: Chakraborty, Debdulal, et al.
Publicado: (2021)

Response to comment on: Anatomical and functional outcomes one year after vitrectomy and retinal massage for large macular holes
por: Chakraborty, Debdulal, et al.
Publicado: (2021)

Response to comment on: Anatomical and functional outcomes one year after vitrectomy and retinal massage for large macular holes
por: Chakraborty, Debdulal, et al.
Publicado: (2021)

Current pattern of ophthalmologists’ awareness and importance of HbA1c in managing diabetic retinopathy patients
por: Ghoshal, Tulika, et al.
Publicado: (2021)

Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021)

Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
por: Ratra, Dhanashree, et al.
Publicado: (2021)

Diabetic papillopathy treated with intravitreal ranibizumab
por: Yildirim, Mine, et al.
Publicado: (2017)

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
por: Jung, Byung Ju, et al.
Publicado: (2019)

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study
por: Korol, Andrii R, et al.
Publicado: (2017)

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy
por: McAllister, Ian L, et al.
Publicado: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Resolution of subretinal abscess from presumed Nocardia chorioretinitis with serial intravitreal amikacin
por: Scavelli, Kurt, et al.
Publicado: (2019)

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
Publicado: (2017)

Systemic combined with intravitreal methotrexate for relentless placoid chorioretinitis: A case report
por: Luo, Lan, et al.
Publicado: (2022)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fi8b30rqi9rb5kcnsjjlh5gtuf